Showing results (121-130 of 183) with videos related to
Sort By:
Pageof 19
Science'S STKE : Signal Transduction Knowledge Environment|July 7, 2005
Signals from the pastL Bryan Ray, Elizabeth M Adler, Nancy R GoughNeurology|June 10, 2009
Redefining functionality and treatment efficacy in multiple sclerosisJohn F Foley, David W BrandesInternational Journal of MS Care|January 24, 2014
Successful management of a neurology infusion practiceJohn F Foley, Anne M DunneBiologics : Targets & Therapy|December 11, 2013
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionKavitha Damal, Emily Stoker, John F FoleyJournal of Managed Care Pharmacy : JMCP|February 7, 2013
Evidence for long-term use of intramuscular interferon beta-1a: an overview of relapse, disability, and MRI data from selected clinical trialsJohn F Foley, Kristine Zerkowski, Kavita V NairJournal of Managed Care Pharmacy : JMCP|February 7, 2013
Emerging methods for evaluating the effectiveness of intramuscular interferon beta-1a for relapsing-remitting multiple sclerosisJohn F Foley, Christopher J Barnes, Kavita V NairCurrent Treatment Options in Neurology|April 15, 2009
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John F Foley, Noel G CarlsonCirculation|August 16, 2006
Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathwayJana Barlic, Yuan Zhang, John F Foley, et al.The Journal of Biological Chemistry|March 19, 2004
On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2Jeremy J Rose, John F Foley, Philip M Murphy, et al.Multiple Sclerosis and Related Disorders|April 3, 2019
Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosingJohn F Foley, Susan Goelz, Tamara Hoyt, et al.Pageof 19